Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric PatientsVIRUSES-BASELIF3.52024-05-281OAAI
Adverse Drug Reactions Due to Opioid Use in Oldest-Old Patients Visiting the Emergency Unit of the Geneva Geriatric HospitalJOURNAL OF FRAILTY & AGINGIF3.32022-07-011PRE
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced ActivityFRONTIERS IN PSYCHIATRYIF3.22022-06-231OAAI
Fracture Risk Following an Atypical Femoral FractureJOURNAL OF BONE AND MINERAL RESEARCHIF5.92021-10-2011OAAI
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJOURNAL OF PERSONALIZED MEDICINEIF32020-10-2710OAAI
Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patientsLIVER INTERNATIONALIF5.22019-11-1223OAAI
Cefepime plasma concentrations and clinical toxicity: a retrospective cohort studyCLINICAL MICROBIOLOGY AND INFECTIONIF8.52017-07-01102OAAI
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPHARMACOLOGICAL RESEARCHIF10.52017-04-0114OAAI
Meta-xylene: identification of a new antigenic entity in hypersensitivity reactions to local anestheticsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62016-01-0111PRE
Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case StudyCLINICAL THERAPEUTICSIF3.62016-01-0114PREAI
VINCRISTINE-INDUCED NEUROPATHIC PAIN IN A CYP3A5 NON-EXPRESSER WITH REDUCED CYP3A4 ACTIVITYCLINICAL THERAPEUTICSIF3.62015-08-010OAAI
SCREENING FOR PHENOTYPICAL VARIATION IN CYP ACTIVITY IN PATIENTS WITH THERAPEUTIC PROBLEM IN PSYCHIATRIC SETTINGSCLINICAL THERAPEUTICSIF3.62015-08-010PREAI
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientAIDSIF3.12012-11-2817OAAI
Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates A Case Series from a Swiss University HospitalDRUG SAFETYIF3.82009-09-01108PREAI